U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07775404) titled 'A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus' on Aug. 17.

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of elecoglipron compared with placebo adjunct to diet and exercise for weight management, in adult participants living with obesity or overweight with or without T2DM.

Study Start Date: Aug. 28

Study Type: INTERVENTIONAL

Condition: Obesity Overweight

Intervention: DRUG: Elecoglipron

Elecoglipron film coated tablet once daily

DRUG: Placebo

Placebo matching elecoglipron film-coated ta...